INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $346,555 | -83.0% | 10,960 | -78.1% | 0.00% | -83.3% |
| Q2 2023 | $2,042,179 | +47.2% | 50,078 | +34.5% | 0.02% | +38.5% |
| Q1 2023 | $1,387,447 | +12.7% | 37,227 | +69.4% | 0.01% | +30.0% |
| Q3 2022 | $1,231,000 | -47.0% | 21,970 | -51.1% | 0.01% | -56.5% |
| Q2 2022 | $2,324,000 | +33.9% | 44,900 | +87.9% | 0.02% | +43.8% |
| Q1 2022 | $1,736,000 | -54.6% | 23,900 | +1.3% | 0.02% | -61.0% |
| Q2 2021 | $3,822,000 | +120.4% | 23,600 | -26.0% | 0.04% | +78.3% |
| Q4 2020 | $1,734,000 | +688.2% | 31,880 | +179.1% | 0.02% | +27.8% |
| Q4 2017 | $220,000 | -1.3% | 11,424 | +9.4% | 0.02% | -64.0% |
| Q2 2016 | $223,000 | – | 10,443 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |